Shanghai Yizhong Pharmaceutical Co., Ltd.

SHSE:688091 Stock Report

Market Cap: CN¥6.3b

Shanghai Yizhong Pharmaceutical Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Jingsong Zhou

Chief executive officer

CN¥824.3k

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership19.5%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Concerns Surrounding Shanghai Yizhong Pharmaceutical's (SHSE:688091) Performance

Apr 15
Concerns Surrounding Shanghai Yizhong Pharmaceutical's (SHSE:688091) Performance

Getting In Cheap On Shanghai Yizhong Pharmaceutical Co., Ltd. (SHSE:688091) Is Unlikely

Mar 29
Getting In Cheap On Shanghai Yizhong Pharmaceutical Co., Ltd. (SHSE:688091) Is Unlikely

CEO

Jingsong Zhou (55 yo)

no data

Tenure

CN¥824,300

Compensation

Mr. Zhou Jingsong serves as Chairman of the Board and General Manager at Shanghai Yizhong Pharmaceutical Co., Ltd.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.